Electronic Cigarette Use, Misuse, and harm.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Kathuria (2022)
high School Youth and E-cigarettes: The Influence of Modified Risk Statements and Flavors on E-cigarette Packaging.
Population Clinical
Effect Of Packaging & Labelling On Perception Of Risk
Katz (2020)
Vaping Flavors and Flavor Representation: a Test of Youth Risk Perceptions, Novelty Perceptions, and Susceptibility.
Population Clinical
Perception Of Risk; Consumer Use
Flavor Appeal
Katz (2023)
Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products
Individual Clinical
Biomarkers
Biomarkers Of Harm
Kaur (2018)
Immunological and toxicological risk assessment of e-cigarettes
Non-Clinical
Immunotoxicity
Kaur (2018)
Differential plasma exosomal long non-coding RNas expression profiles and their emerging role in E-cigarette users, cigarette, waterpipe, and dual smokers.
Nonclinical
Genotoxicity
In Vivo
Kaur (2020)
“Taking Up a New Problem”: Context and Determinants of Pod-Mod Electronic Cigarette Use among College Students.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Kava (2021)
Multicomponent analysis of Replacement Liquids of Electronic Cigarettes Using Chromatographic Techniques
Non-Clinical
Chemical
Analysis
Kavvalakis (2015)
Young adult perspectives on their respiratory health symptoms since vaping.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Kechter (2021)
a chocolate cake or a chocolate vape? Young adults describe their relationship with food and weight in the context of nicotine vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Kechter (2022)